Literature DB >> 1693599

Changes in glycolipid expression in human testicular tumor.

C Ohyama1, Y Fukushi, M Satoh, S Saitoh, S Orikasa, E Nudelman, M Straud, S Hakomori.   

Abstract

Glycolipids were extracted from testicular tumor tissues of 13 patients, and their pattern of expression compared with that of normal testicular tissue. The most conspicuous and consistent change in the tumor extracts was marked accumulation of CTH (ceramide trihexoside). Structural analysis by enzyme cleavage showed that CTH which accumulated in the tumor tissue was Gb3 (Gal alpha 1-4Gal beta 1-4Glc beta 1-Cer). Immunohistochemistry using anti-Gb3 monoclonal antibody (MAb) (1A4) also indicated massive accumulation of Gb3 in the tumor tissue. Gb3 may be a new marker of testicular tumors, especially seminomas, for which useful markers are so far lacking.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693599     DOI: 10.1002/ijc.2910450610

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

Authors:  Maria Teresa Tarragó-Trani; Brian Storrie
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

2.  The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer.

Authors:  Olga Kovbasnjuk; Rakhilya Mourtazina; Boris Baibakov; Thomas Wang; Christian Elowsky; Michael A Choti; Anne Kane; Mark Donowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Biochemical, pathological and oncological relevance of Gb3Cer receptor.

Authors:  D Đevenica; V Čikeš Čulić; A Vuica; A Markotić
Journal:  Med Oncol       Date:  2010-11-11       Impact factor: 3.064

4.  Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ.

Authors:  J L Kang; E Rajpert-De Meyts; J Wiels; N E Skakkebaek
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Authors:  Shingo Hatakeyama; Atsushi Kyan; Hayato Yamamoto; Akiko Okamoto; Naoki Sugiyama; Yuichiro Suzuki; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Shigeyuki Yamada; Hideo Saito; Yoichi Arai; Minoru Fukuda; Chikara Ohyama
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

6.  Expression of L-PHA-binding proteins in breast cancer: reconstitution and molecular characterization of beta 1-6 branched oligosaccharides in three-dimensional cell culture.

Authors:  Y Taeda; M Nose; S Hiraizumi; N Ohuchi
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.

Authors:  H Farkas-Himsley; R Hill; B Rosen; S Arab; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 8.  Shiga toxin and its use in targeted cancer therapy and imaging.

Authors:  Nikolai Engedal; Tore Skotland; Maria L Torgersen; Kirsten Sandvig
Journal:  Microb Biotechnol       Date:  2011-01       Impact factor: 5.813

9.  Glycolipids of human primary testicular germ cell tumours.

Authors:  R A Olie; B Fenderson; K Daley; J W Oosterhuis; J Murphy; L H Looijenga
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

Review 10.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.